Primary study · included by 1 review
Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study.
Schott Andersen 2022 · Schott Andersen Anne Sofie, Maarbjerg Stine, Noory Navid, et al. · The Lancet. Neurology · 2022
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.